Henrichs Timothy Robert 4

What Happened Timothy Robert Henrichs, Chief Financial Officer of Neuraxis, Inc., was granted 75,231 restricted stock units (RSUs) on January 22, 2026. The grant is reported at $4.63 per share for a total value of approximately $348,320. This was an award (derivative acquisition), not an open-market purchase or sale — RSUs are compensation that convert to shares only as they vest.

Key Details

• Transaction date and value: 2026-01-22; 75,231 RSUs at $4.63 per share; total reported value ~$348,320.
• Shares owned after transaction: not specified in the Form 4 filing provided.
• Footnote: The RSUs were granted under the Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan and vest in three equal annual installments over three years.
• Filing timeliness: Transaction dated 2026-01-22; Form 4 was filed 2026-02-26 (35 days later). Form 4s are typically due within two business days of the transaction, so this filing appears late.

Context RSUs are a common form of executive compensation and typically vest over time subject to service or performance conditions; they represent a future right to common stock rather than immediate share ownership. Because this is a compensation grant (not a purchase or sale), it should be viewed as part of Henrichs' pay/retention package rather than a direct market sentiment signal. The filing does not indicate any 10b5-1 plan or tax-withholding sale associated with the grant.